Evidence map›Paper›PMID 42690303›Full record

ArticleArquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery2026

Size alone is not enough: Ki-67 and invasion patterns identify high-risk pancreatic neuroendocrine tumors.

Dante Altenfelder Silva Mesquita Cortelli, Silvio Melo Torres, Igor Correia de Farias, Alessandro Landskron Diniz, Heber Salvador de Castro Ribeiro, André Luis de Godoy, Caroline Almeida Gonçalves, Felipe José Fernández Coimbra

Abstract read
In one paragraph

Article in Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dante Altenfelder Silva Mesquita CortelliAC Camargo Cancer Center, Abdominal Surgery Unit - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0002-8448-8634
Silvio Melo TorresAC Camargo Cancer Center, Abdominal Surgery Unit - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0001-7274-3602
Igor Correia de FariasAC Camargo Cancer Center, Abdominal Surgery Unit - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0002-4258-8004
Alessandro Landskron DinizAC Camargo Cancer Center, Abdominal Surgery Unit - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0001-9671-2026
Heber Salvador de Castro RibeiroAC Camargo Cancer Center, Abdominal Surgery Unit - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0002-3412-7451
André Luis de GodoyAC Camargo Cancer Center, Abdominal Surgery Unit - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0002-7154-1184
Caroline Almeida GonçalvesAC Camargo Cancer Center, Abdominal Surgery Unit - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0003-3363-5275
Felipe José Fernández CoimbraAC Camargo Cancer Center, Abdominal Surgery Unit - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0001-5068-0639

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPancreatic neuroendocrine tumors (pNETS) constitute a heterogeneous and rare disease worldwide. Diagnosis rates have been increasing, and the evaluation of prognostic factors has become even more important in the treatment decision-making process.

aimsTo present results and prognostic factors in patients undergoing surgical treatment for pNETS at a single Brazilian center.

resultsThe most frequently performed surgical procedure was PCC+S 60.0%. The median hospital stay was 8 (5-13) days, and postoperative mortality occurred in 1.7%. Overall survival in 3 and 5 years was 93.8 and 92.1%, respectively. Disease-free survival at 3 and 5 years was 87.1 and 71.8%, respectively. Patients with tumors smaller than 2.0 cm did not present with lymph node disease or recurrence, and patients with tumors measuring 2.1-2.5cm had lymph node disease in 11.1% and recurrence in 11.1%. In univariate and multivariate analysis, the presence of lymphatic and perineural invasion and Ki67 (3-20) were strongly correlated with positive lymph node disease and recurrence, respectively.

conclusionsThe presence of lymphatic and perineural invasion, Ki67 (3 to 20), and tumors larger than 2.5 cm correlated with positive lymph node disease and recurrence.

Indexed as

Ki-67 AntigenNeuroendocrine TumorsPancreatic NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedNeoplasm InvasivenessPrognosisRetrospective StudiesRisk AssessmentTumor BurdenKi-67 Antigen

Identifiers

PMID42690303
PMCPMC13529262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.